Wang, X., Ruan, D., Sun, Y., Niu, Z., Ying, J., Wan, L., Zhang, Y., Gu, K., Xu, H., Hu, H., Lu, L., Gong, W., Liu, Y., Chao, C., Song, S. Q., Li, S., Xu, R. (2026). A phase Ib/IIa study of BAT8010+BAT1006, an anti-HER2 monoclonal antibody-exatecan conjugate combined with an ADCC-enhanced HER2 mAb in patients with advanced solid tumors: Results from the HER2-positive GC/GEJC cohort.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16034